Loading…
Reported covered position: Legislative Director for Rep. Gene Green from 2003-2012
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Further Additional Continuing Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers
Further Additional Continuing Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALKERMES, INC. via ALKERMES, INC.
2019 · third_quarter · Q3
Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues: HR3 - Lower Drug Costs Now Act; S2543 - Prescription Drug Pricing Reduction Act Medicare Part D Restructuring
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers
Source: Senate LDA
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5)
Further Additional Continuing Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5)
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act
Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues: HR3 - Lower Drug Costs Now Act; S2543 - Prescription Drug Pricing Reduction Act Medicare Part D Restructuring
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers
Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues: HR3 - Lower Drug Costs Now Act; S2543 - Prescription Drug Pricing Reduction Act Medicare Part D Restructuring
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness Legislation to promote treatment amongst incarcerated individuals with serious mental illness
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2456/HR 5311 - Comprehensive Addiction and Recovery 2.0 Act of 2018
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2456/HR 5311 - Comprehensive Addiction and Recovery 2.0 Act of 2018
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018 PL# 114-198 - 21st Century Cures Opioid implementation
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R.5786 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 S.3024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 H.R.5952 Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3072 115th Congress (2017-2018) Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3156 (2017-2018) Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2019 House Discussion Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Energy and Water, Legislative Branch, and Military Construction and Veterans Affairs Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R. 6157 - Appropriations for DOD, Labor/HHS/Education and Continuing Appropriations for all other agencies H.R. 5895 - The Energy and Water Development and Related Agencies Appropriations Act
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R.5786 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 S.3024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 H.R.5952 Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3072 115th Congress (2017-2018) Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3156 (2017-2018) Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2019 House Discussion Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018 PL# 114-198 - 21st Century Cures Opioid implementation
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R. 6157 - Appropriations for DOD, Labor/HHS/Education and Continuing Appropriations for all other agencies H.R. 5895 - The Energy and Water Development and Related Agencies Appropriations Act
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings HR 695 - Department of Defense Appropriations Act 5.756 - First Step Act
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2456/HR 5311 - Comprehensive Addiction and Recovery 2.0 Act of 2018
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2456/HR 5311 - Comprehensive Addiction and Recovery 2.0 Act of 2018
Comprehensive Opioid Recovery Centers Act of 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018 PL# 114-198 - 21st Century Cures Opioid implementation
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018 PL# 114-198 - 21st Century Cures Opioid implementation
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R.5786 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 S.3024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 H.R.5952 Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3072 115th Congress (2017-2018) Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3156 (2017-2018) Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2019 House Discussion Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R.5786 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 S.3024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 H.R.5952 Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3072 115th Congress (2017-2018) Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3156 (2017-2018) Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2019 House Discussion Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R.5786 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 S.3024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 H.R.5952 Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3072 115th Congress (2017-2018) Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3156 (2017-2018) Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2019 House Discussion Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness H.R 1628, Better Care Reconciliation Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness H.R 1628, Better Care Reconciliation Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness H.R 1628, Better Care Reconciliation Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness H.R 1628, Better Care Reconciliation Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017
Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL#115-31 Consolidated Appropriations Act of 2017 FY18 Appropriations Act H.R.2998 Military Construction, Veterans Affairs, & Related Agencies Appropriations Act of 2018 Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018
Client: ALKERMES, INC. · Firm: ALKERMES, INC.
Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL#115-31 Consolidated Appropriations Act of 2017 FY18 Appropriations Act H.R.2998 Military Construction, Veterans Affairs, & Related Agencies Appropriations Act of 2018 Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017
Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017
Maintain Medicare's six protected class for depression and schizophrenia S. 648, Medicare Formulary Improvement Act of 2015
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness Legislation to promote treatment amongst incarcerated individuals with serious mental illness
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
ALKERMES, INC. via ALKERMES, INC.
2019 · second_quarter · Q2
Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
ALKERMES, INC. via ALKERMES, INC.
2019 · first_quarter · Q1
Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
ALKERMES, INC. via ALKERMES, INC.
2018 · fourth_quarter · Q4
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings HR 695 - Department of Defense Appropriations Act 5.756 - First Step Act
Maintain six protected classes for depression and schizophrenia under Medicare Part D Drug pricing issues
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018 PL# 114-198 - 21st Century Cures Opioid implementation
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
ALKERMES, INC. via ALKERMES, INC.
2018 · third_quarter · Q3
Public law #114-198, 21st Century Cures Opioid Implementation Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R. 6157 - Appropriations for DOD, Labor/HHS/Education and Continuing Appropriations for all other agencies H.R. 5895 - The Energy and Water Development and Related Agencies Appropriations Act
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act S. 2680 - the Opioid Crisis Response Act of 2018
Maintain six protected classes for depression and schizophrenia under Medicare Part D
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
ALKERMES, INC. via ALKERMES, INC.
2018 · second_quarter · Q2
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 HR 6 - SUPPORT for Patient and Communities Act
Maintain six protected classes for depression and schizophrenia under Medicare Part D
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act H.R.5786 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 S.3024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019 H.R.5952 Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3072 115th Congress (2017-2018) Commerce, Justice, Science and Related Agencies Appropriations Act, 2019 S.3156 (2017-2018) Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2019 House Discussion Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
ALKERMES, INC. via ALKERMES, INC.
2018 · first_quarter · Q1
Public law #114-198, 21st Century Cures Opioid Implementation Awareness of outcomes data and the need for training on all medication assisted treatment
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL 115-141 Consolidated Appropriations Act of 2018 Ensure availability of all treatments for addiction through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
ALKERMES, INC. via ALKERMES, INC.
2017 · fourth_quarter · Q4
Maintain six protected classes for depression and schizophrenia under Medicare Part D
Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL 115-90 Continuing Appropriations for FY18 PL 115-96 To amend the HomeLand Security Act of 2002 Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
ALKERMES, INC. via ALKERMES, INC.
2017 · third_quarter · Q3
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness H.R 1628, Better Care Reconciliation Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017
Maintain Medicare's six protected classes for depression and schizophrenia
ALKERMES, INC. via ALKERMES, INC.
2017 · second_quarter · Q2
Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017
Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL#115-31 Consolidated Appropriations Act of 2017 FY18 Appropriations Act H.R.2998 Military Construction, Veterans Affairs, & Related Agencies Appropriations Act of 2018 Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
ALKERMES, INC. via ALKERMES, INC.
2017 · first_quarter · Q1
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Maintain Medicare's six protected class for depression and schizophrenia S. 648, Medicare Formulary Improvement Act of 2015
Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings Funding of Comprehensive Addiction and Recovery Act FY17 Appropriations FY18 Appropriations Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
Public law #114-198, 21st Century Cures Opioid Implementation Awareness of outcomes data and the need for training on all medication assisted treatment
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Maintain six protected classes for depression and schizophrenia under Medicare Part D
Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments HR 5327 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2589 - Comprehensive Opioid Recovery Centers Act of 2018 S. 2456/HR 5311 - Comprehensive Addiction and Recovery 2.0 Act of 2018
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Confronting the opioid and mental illness epidemic Awareness of the need for treatment system reform and access to all FDA-approved medications
Public law #114-198, 21st Century Cures Opioid Implementation Awareness of outcomes data and the need for training on all medication assisted treatment
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Advance the use, and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings PL#114-198 Funding and implementation of Comprehensive Addiction and Recovery Act PL#115-31 Consolidated Appropriations Act of 2017 FY18 Appropriations Act H.R.2998 Military Construction, Veterans Affairs, & Related Agencies Appropriations Act of 2018 Ensure availability of all treatments for addiction in the Veterans Affairs and Indian Health Services, and through the Substance Abuse & Mental Health Services Administration. Advance use of addiction medicines in the Bureau of Prisons and within criminal justice funding (Byrne Jag)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Maintain Medicare's six protected classes for depression and schizophrenia
Confronting the opioid and mental illness epidemic HR 1682 America Health Care Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness H.R 1628, Better Care Reconciliation Act of 2017, Coverage for the treatment of opioid dependence & serious mental illness
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Public law #114-198, Cures Opioid Funding Implementation Reauthorization of the Prescription Drug User Fee Act (PDUFA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)